Pharmaron Beijing Co., Ltd. (3759.HK)

HKD 14.46

(7.11%)

Total Assets Summary of Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.'s latest annual total assets in 2023 was 26.47 Billion CNY , up 29.2% from previous year.
Pharmaron Beijing Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 22.99 Billion CNY , down -8.9% from previous quarter.
Pharmaron Beijing Co., Ltd. reported annual total assets of 20.49 Billion CNY in 2022, up 11.44% from previous year.
Pharmaron Beijing Co., Ltd. reported annual total assets of 18.38 Billion CNY in 2021, up 54.42% from previous year.
Pharmaron Beijing Co., Ltd. reported quarterly total assets of 25.24 Billion CNY for 2024 Q1, down -4.66% from previous quarter.
Pharmaron Beijing Co., Ltd. reported quarterly total assets of 23.57 Billion CNY for 2024 Q3, up 2.49% from previous quarter.

Annual Total Assets Chart of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Historical Annual Total Assets of Pharmaron Beijing Co., Ltd. (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	26.47 Billion CNY	29.2%
2022	20.49 Billion CNY	11.44%
2021	18.38 Billion CNY	54.42%
2020	11.9 Billion CNY	19.87%
2019	9.93 Billion CNY	114.79%
2018	4.62 Billion CNY	18.02%
2017	3.91 Billion CNY	39.74%
2016	2.8 Billion CNY	138.78%
2015	1.17 Billion CNY	26.1%
2014	931.46 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	22.99 Billion CNY	-8.9%
2024 Q1	25.24 Billion CNY	-4.66%
2024 Q3	23.57 Billion CNY	2.49%
2023 Q2	22.39 Billion CNY	6.38%
2023 Q3	22.47 Billion CNY	0.38%
2023 Q4	26.47 Billion CNY	17.8%
2023 FY	26.47 Billion CNY	29.2%
2023 Q1	21.04 Billion CNY	2.71%
2022 Q3	19.7 Billion CNY	3.9%
2022 FY	20.49 Billion CNY	11.44%
2022 Q1	18.66 Billion CNY	1.48%
2022 Q4	20.49 Billion CNY	3.99%
2022 Q2	18.96 Billion CNY	1.64%
2021 FY	18.38 Billion CNY	54.42%
2021 Q4	18.38 Billion CNY	4.86%
2021 Q3	17.53 Billion CNY	2.93%
2021 Q2	17.03 Billion CNY	33.5%
2021 Q1	12.76 Billion CNY	7.16%
2020 Q2	9.98 Billion CNY	7.62%
2020 Q4	11.9 Billion CNY	13.56%
2020 Q3	10.48 Billion CNY	5.03%
2020 FY	11.9 Billion CNY	19.87%
2020 Q1	9.27 Billion CNY	-6.62%
2019 FY	9.93 Billion CNY	114.79%
2019 Q2	5.34 Billion CNY	3.96%
2019 Q4	9.93 Billion CNY	78.23%
2019 Q1	5.14 Billion CNY	11.2%
2019 Q3	5.57 Billion CNY	4.24%
2018 Q2	4.26 Billion CNY	0.0%
2018 Q1	- CNY	-100.0%
2018 FY	4.62 Billion CNY	18.02%
2018 Q4	4.62 Billion CNY	3.31%
2018 Q3	4.47 Billion CNY	4.97%
2017 FY	3.91 Billion CNY	39.74%
2017 Q4	3.91 Billion CNY	0.0%
2016 FY	2.8 Billion CNY	138.78%
2015 FY	1.17 Billion CNY	26.1%
2014 FY	931.46 Million CNY	0.0%

Peer Total Assets Comparison of Pharmaron Beijing Co., Ltd.

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-6357.861%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	-135.403%